Ferrocene‐induced lymphocyte activation and antitumor activity is mediated by redox‐sensitive signaling
Author:
Affiliation:
1. Felsenstein Medical Research CenterSackler Faculty of MedicineTel Aviv UniversityRabin Medical Center ‐ Beilinson CampusPetah‐Tikva49100Israel
2. Department of BiochemistryWeill Medical College of Cornell UniversityNew YorkNew York10021USA
Publisher
Wiley
Subject
Genetics,Molecular Biology,Biochemistry,Biotechnology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.02-0558fje
Reference32 articles.
1. Interleukin‐2 in the treatment of renal cancer;Margolin K. A.;Semin. Oncol.,2000
2. The prospects for therapy with tumour necrosis factors and their antagonists
3. Adoptive Immunotherapy With Tumor-Infiltrating Lymphocytes and Subcutaneous Recombinant Interleukin-2 Plus Interferon Alfa-2a for Melanoma Patients With Nonresectable Distant Disease: A Phase I/II Pilot Trial
4. Recombinant interleukin‐2‐based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group;Keilholz U.;Cancer J. Sci. Am.,1997
5. Interleukin‐2‐based therapy for metastatic renal cell cancer: the Cytokine Working Group experience, 1989‐1997;Dutcher J. P.;Cancer J. Sci. Am.,1997
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Programmable Release of Chemotherapeutics from Ferrocene‐Based Injectable Hydrogels Slows Melanoma Growth;Advanced Healthcare Materials;2024-07-15
2. Revisiting metallodrugs for the treatment of skin cancers;Coordination Chemistry Reviews;2022-07
3. Ferrocene-functionalized anilines as potent anticancer and antidiabetic agents: Synthesis, spectroscopic elucidation, and DFT calculations;Journal of Molecular Structure;2022-02
4. Metallodrugs in cancer nanomedicine;Chemical Society Reviews;2022
5. The Cytotoxic Effect of Newly Synthesized Ferrocenes against Cervical Carcinoma Cells Alone and in Combination with Radiotherapy;Applied Sciences;2020-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3